-
CA-074 Me: Unlocking Lysosomal Protease Inhibition in Nec...
2025-10-23
Explore how CA-074 Me, a potent cathepsin B inhibitor, enables advanced dissection of lysosomal membrane permeabilization and necroptosis. This article delves deeper into the mechanistic interplay between MLKL polymerization, lysosomal signaling, and apoptosis, offering unique insights for inflammation and cell death research.
-
Strategic Targeting of Cathepsin B in Lysosomal Cell Deat...
2025-10-22
This thought-leadership article explores the critical role of cathepsin B-mediated lysosomal membrane permeabilization (LMP) in regulated cell death, integrating recent mechanistic revelations with actionable strategies for translational researchers. By leveraging the membrane-permeable, selective cathepsin B inhibitor CA-074 Me, we outline how scientists can dissect necroptosis, apoptosis, and inflammation with unprecedented precision—moving beyond traditional approaches and into the vanguard of therapeutic discovery.
-
Strategic Targeting of Cathepsin B: Advancing Necroptosis...
2025-10-21
This thought-leadership article unpacks the critical role of cathepsin B in regulated cell death, integrating recent mechanistic breakthroughs on MLKL-induced lysosomal membrane permeabilization (LMP) and necroptosis. It offers translational researchers actionable experimental and strategic guidance on utilizing CA-074 Me—a highly selective, cell-permeable cathepsin B inhibitor—to dissect and manipulate lysosomal signaling pathways. The discussion contextualizes CA-074 Me within the competitive landscape, highlights clinical relevance, and maps out future directions for disease modulation and translational research, while escalating the conversation beyond standard product literature.